CD4/CD8 ratio as a predictor for the occurrence of metabolic syndrome in HIV / AIDS patients during 6 months of cART therapy
Authors:
Open Access
- 22 January 2019
- journal article
- research article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 38 (4) , 489-495
Abstract
Summary: Background: HIV infection is characterized by progressive depletion of CD4+T cells due to their reduced synthesis and increased destruction followed by marked activation and expansion of CD8+T lymphocytes. CD4/CD8 ratio was traditionally described as a marker of immune system ageing in the general population, but it increasingly appears as a marker of different outcomes in the HIV-infected population. The main objective of this study is to examine the power of CD4/CD8 ratio in predicting the occurrence of metabolic syndrome (MetS) in HIV-positive patients receiving cART therapy.Methods: 80 HIV/AIDS subjects were included in a retrospective case-control study. Flow cytometry was used to determine the percentage of CD4+and CD8+cells in peripheral blood of these patients. The values of biochemical parameters (triglycerides, HDL, blood sugar, blood counts), immunological parameters (CD4/CD8, PCR), anthropometric measurements and type of cART therapy were evaluated in this study.Results: After six months of cART therapy 19 (23.8%) subjects had all the elements necessary for making the diagnosis of MetS. Using multivariate analysis CD4/CD8 ratio was statistically significant (p < 0.05) and had the largest effect on development of MetS (Wald = 9.01; OR = 0.45), followed by cART (Wald = 7.87; OR = 0.10) and triglycerides (Wald = 5.27; OR = 1.7). On the other hand, body weight and waist circumference showed no statistically significant effect on the development of MetS after six months of cART, p > 0.05.Conclusions: CD4/CD8 ratio proved to be a significant marker for prediction of metabolic syndrome in HIV/AIDS patients.Keywords
This publication has 18 references indexed in Scilit:
- A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected PopulationPLOS ONE, 2016
- Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapyAIDS, 2015
- CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort studyThe Lancet HIV, 2015
- Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damageCurrent Opinion in HIV and AIDS, 2015
- HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and MortalityPLOS Pathogens, 2014
- CD4+T Cells: Differentiation and FunctionsJournal of Immunology Research, 2012
- HIV protease inhibitors and obesityCurrent Opinion in Endocrinology, Diabetes and Obesity, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient PopulationClinical Infectious Diseases, 2007
- The Dominant Source of CD4+ and CD8+ T-Cell Activation in HIV Infection Is Antigenic StimulationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000